Why can't I see South Lake Compounding pricing before I commit?

The pricing transparency problem shows up at the worst moment: a patient is in front of you ready to start semaglutide or tirzepatide, and you cannot tell them the cost because your pharmacy does not show landed per-vial pricing before you have a clinic agreement in place. You either guess, quote a padded number to be safe, or tell the patient you will follow up — and follow-ups are where conversions go to die.

For clinic owners, the same opacity makes margin planning a moving target. If the cost per vial is only knowable after a liaison conversation and can shift with volume commitments, building a predictable cash-pay program means working from estimates rather than real numbers. Third-party clinic data confirms this pattern: South Lake's per-vial pricing is generally available to enrolled prescribers through the LifeFile portal, but the path to those numbers runs through enrollment, not through a public catalog.

South Lake Pharmacy is a direct compounder — it makes the medications, so pricing is negotiated as part of the prescriber enrollment process rather than published on a catalog page. That is a deliberate model: clinic agreement pricing can yield favorable rates at volume because there is no intermediary layer, but the trade-off is that you do not see a number until you go through enrollment and LifeFile provisioning.

When you evaluate this model, the right questions are about timing and visibility inside LifeFile: how long from physician enrollment inquiry to usable per-vial numbers, whether rates are visible on each SKU inside the LifeFile ordering view, and how pricing changes if your volume shifts or South Lake's raw material costs move. If pricing is visible in the LifeFile portal after enrollment, the onboarding delay is the main friction. If it is still opaque inside the portal, the quote delay repeats every time a new SKU or quantity tier comes up.

The delay disappears when pricing is visible at the point of decision. Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with the facilitation fee disclosed at payment, so a clinician can quote a patient in the room and an owner can model margin from real numbers — before enrollment, before commitment, and before a single order is placed.

Pass-through pricing is the structural difference: instead of a clinic agreement rate that appears after enrollment, you see the 503A cost and the disclosed facilitation fee on every line in the catalog. The evaluation test is whether you can answer what does this vial cost without calling anyone. When the catalog answers that question, the consult keeps moving and pricing stops being a bottleneck.